People with type 2 diabetes and early kidney disease consistently show low vitamin D levels in their blood, and the worse their kidney function, the lower their vitamin D levels tend to be.
See the scientific wording
Patients with type 2 diabetes and early-stage chronic kidney disease have median 25(OH)D levels below 18 ng/mL across all eGFR stages, with the lowest levels (13 ng/mL) observed in those with the most impaired kidney function.
Correlational — new studies may shift this
ObservationalOne good-quality study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cohort StudyHuman
People with type 2 diabetes and early kidney problems tend to have very low vitamin D levels, and the worse their kidneys are, the lower their vitamin D gets — and this study found exactly that.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
As kidney function declines, the liver produces more vitamin D-binding protein, which traps most of the vitamin D in the blood so it cannot reach the kidneys or other tissues. This prevents the body from using vitamin D properly, causing levels to drop further as kidney damage worsens.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
People with type 2 diabetes and early kidney disease consistently show low vitamin D levels in their blood, and the worse their kidney function, the lower their vitamin D levels tend to be.
Mechanism
1 studyWhen the kidneys start to fail, the liver makes too much of a protein that grabs onto vitamin D and locks it away. This stops vitamin D from doing its job, so levels keep dropping the worse the kidneys get.
As kidney function declines, the liver produces more vitamin D-binding protein, which traps most of the vitamin D in the blood so it cannot reach the kidneys or other tissues. This prevents the body from using vitamin D properly, causing levels to drop further as kidney damage worsens.
Chronic kidney dysfunction triggers increased hepatic synthesis of vitamin D-binding protein in response to hypocalcemia and vitamin D deficiency.
Elevated vitamin D-binding protein binds over 85% of circulating vitamin D and its active metabolite 1,25(OH)2D, reducing the concentration of free, biologically active vitamin D.
Reduced free vitamin D limits delivery to renal tubules, impairing local conversion to the active form 1,25(OH)2D and diminishing calcium absorption in the intestine.
Diminished active vitamin D action reduces renal calcium reabsorption and fails to suppress parathyroid hormone, perpetuating mineral imbalance and further suppressing vitamin D activation.
The sequestration of vitamin D by excess binding protein results in progressively lower serum 25(OH)D levels as kidney function declines, with the lowest levels observed in the most advanced stages of impairment.
Evidence from Studies
Supporting (1)
Community contributions welcome
People with type 2 diabetes and early kidney problems tend to have very low vitamin D levels, and the worse their kidneys are, the lower their vitamin D gets — and this study found exactly that.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of 25(OH)D Levels in Type 2 Diabetes with Early Chronic Kidney Disease Across eGFR Stages
Population: Adults with type 2 diabetes and eGFR 30-89 mL/min/1.73m²; Intervention: None (observational); Comparator: None; Outcome: Median and distribution of serum 25(OH)D levels by eGFR stage; Duration: Not applicable (aggregate of existing studies).
Prospective Cohort Study of 25(OH)D Trajectories in Type 2 Diabetes Patients Across Early Chronic Kidney Disease Progression
Population: Adults with type 2 diabetes and eGFR ≥60 mL/min/1.73m² at baseline; Intervention: None (observational); Comparator: None; Outcome: Serial measurements of serum 25(OH)D and eGFR over 3–5 years; Duration: 3–5 years.
Cross-Sectional Analysis of 25(OH)D Levels by eGFR Stage in a Large Cohort of Type 2 Diabetes Patients with Early Chronic Kidney Disease
Population: Adults with type 2 diabetes and eGFR 30–89 mL/min/1.73m²; Intervention: None; Comparator: eGFR strata (30–44, 45–59, 60–89); Outcome: Median serum 25(OH)D levels per eGFR group; Duration: Single time point.
Case Report of Severe Vitamin D Deficiency (13 ng/mL) in a Type 2 Diabetes Patient with eGFR 25 mL/min/1.73m²
Population: Individual patient with type 2 diabetes and eGFR ≤30 mL/min/1.73m²; Intervention: None; Comparator: None; Outcome: Serum 25(OH)D level and eGFR at time of presentation; Duration: Single visit.
In Vitro Study of Vitamin D Metabolism in Human Proximal Tubule Cells Under High Glucose and Reduced Filtration Conditions
Population: Human proximal tubule cell lines; Intervention: Exposure to high glucose (25 mM) and reduced fluid flow; Comparator: Normal glucose (5.5 mM) and standard flow; Outcome: Expression of CYP27B1 and 25(OH)D conversion rates; Duration: 24–72 hours.